Bristol-Myers Squibb has VOLUNTARILY stopped selling Serzone (nefazodone)

Bristol-Myers Squibb has VOLUNTARILY stopped selling Serzone (nefazodone) in the U.S.

It's already off the market in Europe and Canada.

The company is not saying...but liver toxicity seems to be part of the reason. FDA added a black box warning 2 years ago.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote